Thota, P. N., Alkhayyat, M., Cifuentes, J. D. G., Haider, M., Bena, J., McMichael, J., . . . Sanaka, M. R. (2022). Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma. J Clin Gastroenterol.
Chicago Style CitationThota, Prashanthi N., Motasem Alkhayyat, Juan David Gomez Cifuentes, Mahnur Haider, James Bena, John McMichael, Davender P. Sohal, Siva Raja, i Madhusudhan R. Sanaka. "Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma." J Clin Gastroenterol 2022.
Cita MLAThota, Prashanthi N., et al. "Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma." J Clin Gastroenterol 2022.
Atenció: Aquestes cites poden no estar 100% correctes.